Novel Preoperative Nomogram for Prediction of Futile Resection in Patients Undergoing Exploration for Potentially Resectable Intrahepatic Cholangiocarcinoma
- PMID: 28211504
- PMCID: PMC5314340
- DOI: 10.1038/srep42954
Novel Preoperative Nomogram for Prediction of Futile Resection in Patients Undergoing Exploration for Potentially Resectable Intrahepatic Cholangiocarcinoma
Abstract
Surgical resection is the treatment of choice for intrahepatic cholangiocarcinoma (IHCC). However, discrepancies between preoperative workup and intraoperative findings can occur, resulting in unexpected and unfavorable surgical outcomes. The aim of this study was to develop a feasible preoperative nomogram to predict futile resection of IHCC. A total of 718 patients who underwent curative-intent surgery for IHCC between January 2005 and December 2014 were included. The patients were divided into a training cohort (2005-2010, n = 377) and validation cohort (2011-2014, n = 341). The predictive accuracy and discriminative ability of the nomogram were determined by the concordance index and calibration curves. In multivariate analysis of the training cohort, tumor number, lymph node enlargement, presence of intrahepatic duct stones, and elevated neutrophil-to-lymphocyte ratio (NLR) (≥2.7) were independently correlated with the risk of futile resection. The predictive nomogram was established based on these factors. The concordance index of the nomogram for the training and the validation cohorts was 0.847 and 0.740, respectively. In this nomogram, the negative predictive value (128 points, probability of futile resection of 36%) in the validation cohort was 93.3%. In conclusion, our novel preoperatively applicable nomogram is a feasible method to predict futile resection of IHCC in curative-intent surgery.
Conflict of interest statement
The authors declare no competing financial interests.
Figures



Similar articles
-
A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma.J Surg Res. 2018 Jun;226:56-63. doi: 10.1016/j.jss.2018.01.024. Epub 2018 Feb 10. J Surg Res. 2018. PMID: 29661289
-
Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.Oncotarget. 2016 Jun 14;7(24):37319-37330. doi: 10.18632/oncotarget.9104. Oncotarget. 2016. PMID: 27144432 Free PMC article.
-
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.JAMA Surg. 2014 May;149(5):432-8. doi: 10.1001/jamasurg.2013.5168. JAMA Surg. 2014. PMID: 24599477
-
Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome.Surg Today. 2004;34(11):885-90. doi: 10.1007/s00595-004-2832-3. Surg Today. 2004. PMID: 15526120 Review.
-
The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics.J Gastroenterol. 2015 Sep;50(9):913-27. doi: 10.1007/s00535-015-1071-2. Epub 2015 Apr 2. J Gastroenterol. 2015. PMID: 25833009 Review.
Cited by
-
Development and validation of a nomogram to predict cancer-specific survival with unresected cholangiocarcinoma undergoing external radiotherapy.Front Public Health. 2023 Feb 2;11:1012069. doi: 10.3389/fpubh.2023.1012069. eCollection 2023. Front Public Health. 2023. PMID: 36817916 Free PMC article.
-
Letter to the Editor of Annals of Surgical Oncology Concerning "Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multicenter Study".Ann Surg Oncol. 2025 Jul;32(7):5033-5034. doi: 10.1245/s10434-025-17305-w. Epub 2025 Apr 12. Ann Surg Oncol. 2025. PMID: 40221552 No abstract available.
-
Interpretable machine learning-based clinical prediction model for predicting lymph node metastasis in patients with intrahepatic cholangiocarcinoma.BMC Gastroenterol. 2024 Apr 19;24(1):137. doi: 10.1186/s12876-024-03223-w. BMC Gastroenterol. 2024. PMID: 38641789 Free PMC article.
-
Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease.Cancer Med. 2019 Oct;8(13):5916-5929. doi: 10.1002/cam4.2373. Epub 2019 Aug 20. Cancer Med. 2019. PMID: 31429524 Free PMC article.
-
The prognostic value of neutrophil-to-lymphocyte ratio in cholangiocarcinoma: a systematic review and meta-analysis.Sci Rep. 2022 Jul 25;12(1):12691. doi: 10.1038/s41598-022-16727-w. Sci Rep. 2022. PMID: 35879385 Free PMC article.
References
-
- Shaib Y. H., Davila J. A., McGlynn K. & El-Serag H. B. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J. Hepatol. 40, 472–477 (2004). - PubMed
-
- Bragazzi M. C. et al.. Cholangiocarcinoma: Epidemiology and risk factors. Translational Gastrointestinal Cancer 1, 21–32 (2011).
-
- Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology (Baltimore, Md.) 33, 1353–1357 (2001). - PubMed
-
- Nathan H. et al.. Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 11, 1488–1496, discussion 1496–1487 (2007). - PubMed
-
- Hwang S. et al.. Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 19, 1291–1304 (2015). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical